Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00570_DB01319_nanopub.RAXnoWn9smb170ttFveY1Ciy-TQ695jNKhBN6Z3SmLfHU#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00570_DB01319 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00570_DB01319 label "DDI between Vinblastine and Fosamprenavir - Fosamprenavir, a strong CYP3A4 inhibitor, may decrease the metabolism of Vinblastine. Consider alternate therapy to avoid Vinblastine toxicity. Monitor for changes in the therapeutic/adverse effects of Vinblastine if Fosamprenavir is initiated, discontinued or dose changed. [drugbank_resource:DB00570_DB01319]" assertion.
- drugbank_resource:DB00570_DB01319 identifier "drugbank_resource:DB00570_DB01319" assertion.
- drugbank_resource:DB00570_DB01319 title "DDI between Vinblastine and Fosamprenavir - Fosamprenavir, a strong CYP3A4 inhibitor, may decrease the metabolism of Vinblastine. Consider alternate therapy to avoid Vinblastine toxicity. Monitor for changes in the therapeutic/adverse effects of Vinblastine if Fosamprenavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB00570 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00570_DB01319 assertion.
- drugbank:DB01319 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00570_DB01319 assertion.